BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2010
View Archived Issues
Italian researchers discover new SMO receptor antagonists for cancer
Read More
Austrian scientists describe new GABA(A) receptor ligands
Read More
Daiichi Sankyo claims new ligands of voltage-dependent calcium channel subunit alpha2-delta
Read More
Pfizer discloses new PDE9A inhibitors
Read More
Praecis Pharma identifies novel ADAMTS-4 inhibitors
Read More
MK-4827 receives E.U. orphan drug status in ovarian cancer
Read More
Emergent BioSolutions acquires Trubion Pharmaceuticals
Read More
Topical nitroglycerin improves symptoms of chondrodermatitis nodularis helicis
Read More
Tenofovir vaginal gel reduces risk of HIV infection in women
Read More
Iontophoretically delivered terbinafine enters phase II trial in onychomycosis
Read More
Sipuleucel-T prolongs survival in phase III trial in castration-resistant prostate cancer
Read More
FT-23 attenuates diastolic dysfunction in model of diabetic cardiomyopathy
Read More
Allozyne partners with Sigma-Aldrich for cycloaddition chemistry
Read More
TLV and Emergent BioSolutions to codevelop H5 influenza vaccine
Read More
AVEO completes enrollment in phase III tivozanib trial in renal cell carcinoma
Read More
Dexamethasone intravitreal implant receives E.U. orphan drug status for noninfectious uveitis
Read More
Epitomics spins out new antibody therapeutics company, Apexigen
Read More
Humanetics receives licenses for medical radiation countermeasures
Read More
Novavax reports preclinical data on respiratory syncytial virus vaccine RSV-F
Read More
Stem Cell Therapeutics to begin phase IIa trial of hCG and EPO in traumatic brain injury
Read More
Syndax raises funds for ENCORE-301 trial in breast cancer
Read More
NIH begins phase I trial of its dengue vaccine Tetravax-DV
Read More
CeNeRx secures funds for phase II trial of new CX-157 formulation for depression
Read More
EMA validates CTI's expanded pediatric program for pixantrone in NHL
Read More
FDA grants orphan drug status to BC-819 in pancreatic cancer
Read More